|
|
| | | What you need to know about the coronavirus today |
| |
South Korea to secure vaccines for 60% of its people South Korea said it plans to spend $146 million to procure coronavirus vaccines, initially aiming to secure a supply for 30 million people, or 60% of its population, as it battles persistent outbreaks of new cases.
The population target is higher than a World Health Organization goal for the early purchase of supplies for 20% of the world’s most vulnerable people, and at least 40% agreed by European Union nations, Britain and EU partners for their populations.
South Korea has been one of the world’s coronavirus mitigation success stories, with an aggressive testing and tracing strategy.
Australia records first day without COVID-19 death in two months Australia recorded its first day without a COVID-19 death in two months, as states began to lift restrictions amid growing confidence that a second wave of infections has been contained.
While officials said there were 50 COVID-19 cases in the past 24 hours, a small increase from a day earlier, Australia reported no fresh fatalities for the first time since July 13.
Most of the new cases were in Victoria, Australia’s second most populous state, which has accounted for about 75% of the country’s COVID-19 infections.
Hong Kong to open bars, pools and theme parks Hong Kong will reopen bars, swimming pools and theme parks from Friday as it relaxes coronavirus restrictions after the testing of nearly two million people in a program organized by the Chinese government found 42 cases.
The announcement comes days after the Chinese special administrative region reopened gyms and entertainment venues and increased the number of people allowed to gather to four.
The ban on gatherings of more than four people remains in place as does a ban on people visiting public beaches as authorities called for vigilance.
Hong Kong Disneyland closed on July 15 for a second time this year due to the virus, after having reopened in June.
Party next door in the UK? Call the police British minister Priti Patel said she would call the police to report anyone who flouted a ban on gatherings of more than six people, suggesting that people who stopped for a chat on the street were breaking new coronavirus laws.
COVID-19 cases across the UK have risen sharply in recent weeks, prompting the government to bring in the new rules to restrict socializing, at the same time as health bosses have said there are problems with accessing tests.
The social clampdown comes amid concern that people are struggling to get tests for COVID-19, especially in areas where the infection rates are highest. | |
| |
| |
Reuters reporters and editors around the world are investigating the response to the coronavirus pandemic.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at coronavirus@reuters.com.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how. | |
|
| |
|
|
| | U.S. |
Hurricane Sally drew closer to the U.S. Gulf Coast, threatening historic floods along the coast, the National Hurricane Center said, with more than two feet (61 cms) of rain expected in some areas. The second strong storm in less than a month to threaten the region, Sally’s winds decreased to 85 miles per hour (140 kph), and early Tuesday was 60 miles (100 km) east of the mouth of the Mississippi River, the NHC said, moving at a glacial pace of two miles per hour. | |
| COVID Science |
| |
Rheumatoid arthritis drug found to aid COVID-19 recovery Hospitalized COVID-19 patients being treated with Gilead Sciences Inc’s antiviral medication remdesivir recovered about a day sooner, on average, if they also received Eli Lilly and Co’s rheumatoid arthritis drug baricitinib, clinical trial investigators found.
The trial, sponsored by the U.S. National Institute of Allergy and Infectious Diseases, included more than 1,000 patients. The study also showed that compared to patients who did not receive the arthritis drug, those who did had better outcomes at 15 days after they enrolled in the trial. | |
|
| |
|
|
| | Top Stories on Reuters TV |
|
| |
|
|
|